Sabio Announces LIFE Offering of Up to $4 Million

Executive Summary

• Sabio Holdings entered into a financing agreement with Canaccord Genuity Corp., acting as lead agent and sole bookrunner, to raise up to $4 million through a brokered private placement of common “LIFE” shares at $0.43 per share.
• The offering is being conducted on a best‑efforts basis under the NI 45‑106 listed issuer financing exemption (Canada) and will also be available to accredited U.S. investors under Rule 506(b).
• Closing is expected around November 5, 2025, subject to customary conditions including TSX Venture Exchange approval; net proceeds are earmarked for general corporate purposes and modest expansion of Sabio’s international and creator TV initiatives.

Key Details

• Offering Size: Up to $4 million gross proceeds.
• Share Price: $0.43 per LIFE share.
• Securities Offered: Common shares (“LIFE Shares”).
• Exemptions Used: NI 45‑106 listed issuer financing exemption (Canada, all provinces except Québec); Section 2.3 of OSC Rule 72‑503 for non‑Canadian investors; U.S. accredited investor exemption under Rule 506(b) of Regulation D.
• Lead Agent / Bookrunner: Canaccord Genuity Corp. (sole bookrunner, lead agent).
• Commission & Warrants to Agents:
• Cash commission equal to 6.0% of gross proceeds.
• Warrants exercisable for 6.0% of the number of LIFE shares sold, each warrant allowing purchase of one common share at $0.43 for 24 months post‑closing.
• Reduced to 3.0% commission and warrants for “President’s List” investors.
• Use of Proceeds: Primarily for general corporate and working capital purposes; modest allocations toward further investment in Sabio’s international and creator TV offerings.
• Closing Date: Expected on or about November 5, 2025, subject to receipt of all necessary approvals, including conditional TSXV approval.
• Regulatory Filings: Offering document filed on SEDAR+ (Form 45‑106F19) and available on Sabio’s website.

Notable Quotes

(No direct quotes were provided in the release.)